« A Federation of Independent Researchers? |
| More on the Federation of Independent Scientists: Journal Access »
April 13, 2012
AstraZeneca Cuts Again
I have word today that AstraZeneca has told the scientists at Reims that the French site will be closed by the end of the year, with oncology being "consolidated" in Alderley Park and the Boston area.
It's a good guess, given the patent situation the company's facing and the pipeline it has to deal with it, that this won't be the last announcement of its kind. . .
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- How Not to Do It: NMR Magnets
- Allergan Escapes Valeant
- Vytorin Actually Works
- Fatalities at DuPont
- The New York TImes on Drug Discovery
- How Are Things at Princeton?
- Phage-Derived Catalysts
- Our Most Snorted-At Papers This Month. . .